Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®

Aethlon Medical reported “second cohort” findings that are consistent with previously observed results, and it plans independent statistical analysis after all three patient cohorts are completed. No effect size, efficacy, safety signals, or timeline specifics were provided in the excerpt, limiting near-term interpretability for investors.

Analysis

Aethlon Medical reported “second cohort” findings that are consistent with previously observed results, and it plans independent statistical analysis after all three patient cohorts are completed. No effect size, efficacy, safety signals, or timeline specifics were provided in the excerpt, limiting near-term interpretability for investors.